Background Quantitative MRI is increasingly proposed in clinical trials related to
dystrophinopathies, including Becker muscular dystrophy (BMD). Purpose To establish the …

Purpose Aim of this study is to compare Quantitative Magnetic Resonance Imaging (qMRI)
measures between Becker Muscular Dystrophy (BMD) and Healthy Subjects (HS) and to …

Introduction: With the advent of emerging molecular therapies for muscular dystrophies, the
need for knowledge about natural history course of such diseases is of utmost importance in …

Background Becker muscular dystrophy (BMD) is an X‐linked disorder characterized by
slow, progressive muscle damage and muscle weakness. Hallmarks include fibre‐size …

Introduction Calf hypertrophy is a common feature in Becker muscular dystrophy (BMD), and
it is still debated to which extent fatty degeneration or true muscle hypertrophy account for it …

Objective To identify the best quantitative fat–water MRI biomarker for disease progression
of leg muscles in Becker muscular dystrophy (BMD) by applying a stepwise approach based …

In Becker muscular dystrophy (BMD), muscle weakness progresses relatively slowly, with a
highly variable rate among patients. This complicates clinical trials, as clinically relevant …

Abstract Introduction/Aims Becker muscular dystrophy (BMD) is characterized by variable
disease severity and progression, prompting the identification of biomarkers for clinical trials …

Becker muscular dystrophy (BMD) is characterized by progressive muscle weakness.
Muscles show structural changes (fatty infiltration, fibrosis) and metabolic changes, both of …

Becker muscular dystrophy (BMD) is a neuromuscular disorder allelic to Duchenne
muscular dystrophy (DMD), caused by in-frame mutations in the dystrophin gene, and …